34,270 Shares in Direxion Daily S&P Biotech Bull 3x Shares $LABU Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 34,270 shares of the company’s stock, valued at approximately $3,208,000. JPMorgan Chase & Co. owned 0.53% of Direxion Daily S&P Biotech Bull 3x Shares at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Qube Research & Technologies Ltd acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the second quarter valued at $26,000. RBF Capital LLC acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the second quarter worth about $378,000. Squarepoint Ops LLC boosted its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.2% during the 2nd quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock worth $9,171,000 after acquiring an additional 40,157 shares in the last quarter. Headlands Technologies LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 2nd quarter valued at about $69,000. Finally, Thurston Springer Miller Herd & Titak Inc. grew its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 68.7% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 506 shares of the company’s stock valued at $47,000 after acquiring an additional 206 shares during the period.

Direxion Daily S&P Biotech Bull 3x Shares Stock Performance

Shares of Direxion Daily S&P Biotech Bull 3x Shares stock opened at $171.64 on Friday. Direxion Daily S&P Biotech Bull 3x Shares has a twelve month low of $32.55 and a twelve month high of $198.18. The business has a 50-day moving average price of $162.74 and a 200 day moving average price of $146.81.

Direxion Daily S&P Biotech Bull 3x Shares Profile

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.